Petros Pharmaceuticals share price logo

Petros Pharmaceuticals

OTC: PTPI

$0.01

+0.00

(+49.45%)

as on

Petros Pharmaceuticals Stock Performance

as on October 1, 2026 at 6:05 am IST

  • Day's Low

    Day's High

    $0.01
    $0.01
    downward going graph

    -47.06%

    Downside

    47.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.00
    $0.03
    downward going graph

    75.00%

    Downside

    267.65%

    Upside

    downward going graph

Petros Pharmaceuticals share price movements today

Previous Close
$0.00
Open
$0.01
Volume
735.2K
Market Cap
$211.9K
Day's Low - High
$0.01 - $0.01
52 Week Low - High
$0.00 - $0.03

Petros Pharmaceuticals Historical Returns

1 Month Return
+ 36 %
3 Month Return
+ 33.33 %
1 Year Return
-72.8 %
3 Year Return
-99.98 %
5 Year Return
-100 %

Petros Pharmaceuticals Stock Fundamentals & Key Indicators

Check Petros Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$211.9K

EPS (TTM)

8.5111

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-5.55

PEG Ratio

0.00

EBITDA

-2.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-147.02%

Petros Pharmaceuticals stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Petros Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$211.9K-100.00%NA0.00%0.00%

Stock Returns calculator for Petros Pharmaceuticals Stock including INR - Dollar returns

The Petros Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Petros Pharmaceuticals investment value today

Current value as on today

₹29,340

Returns

-₹70,660

(-70.66%)

Returns from Petros Pharmaceuticals Stock

-₹72,800 (-72.8%)

Dollar Impact

₹2,140 (+2.14%)

Analyst Recommendation on Petros Pharmaceuticals Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Petros Pharmaceuticals. Average target price of $1

Petros Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Petros Pharmaceuticals.

What analysts predicted

99.32%UPSIDE

Target Price

$1

Current Price

$0.0068

Analyzed by

7 Analysts

Target

$1.00

Petros Pharmaceuticals target price $1, a slight upside of 99.32% compared to current price of $0.0068. According to 7 analysts rating.

Petros Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
1
1
0
-
-
-
-
-
-
Gross Profit
0
1
1
0
-
-
-
-
-
-
Operating Income
-3
-2
-2
-9
-1
-1
0
0
-1
0
EBITDA
-1
0
-1
-8
-1
-2
0
0
0
0
Interest Expense
0
0
0
0
-
-
-
-
-
-
Depreciation
0
0
0
0
-
-
0
-
-
-
Income Before Tax
-2
0
-2
-9
-1
-2
0
0
0
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
0
-2
-9
-2
5
0
0
0
0
Net Profit Margin
24.42%
76.85%
81.79%
63.50%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Petros Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
14
15
9
7
5
5
5
-
Gross Profit
3
2
5
6
3
4
3
-
Operating Income
-7
-19
-17
-18
-19
-13
-17
-4
EBITDA
0
-14
-12
-1
-13
-4
-10
-4
Interest Expense
-
13
3
0
0
0
0
-
Depreciation
8
5
6
6
5
3
2
-
Income Before Tax
-32
-33
-22
-8
-20
-8
-14
-4
Income Tax Expense
0
0
-1
-
-
-
-
-
Net Income
-32
-32
-20
-8
-20
-8
-14
1
Net Profit Margin
25.41%
18.35%
57.67%
79.52%
61.79%
71.98%
76.28%
0.00%

Petros Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
-2
-9
-1
4
0
0
0
0
Operating Cash Flow
-1
-1
0
0
-1
-3
-1
0
0
0
Investing Cash Flow
-
-
0
0
-
-
-
-
-
-
Financing Cash Flow
-1
-1
-2
-1
8
0
0
-
-
-
Change in Cash
-2
-3
-3
0
7
-3
-1
0
0
0

Petros Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-32
-32
-20
-8
-20
-8
-14
2
Operating Cash Flow
8
2
-15
-11
-12
-7
-2
-6
Investing Cash Flow
-1
0
0
-
-
-
0
-
Financing Cash Flow
-2
-3
30
18
-1
11
-6
8
Change in Cash
3
0
14
6
-14
3
-9
1

Global Institutional Holdings in Petros Pharmaceuticals

Check out the Institutions with significant holdings in Petros Pharmaceuticals.

Funds
Holdings
Vanguard Group Inc
0.06%
Bank of America Corp
0.00%
BlackRock Inc
0.00%
TWO SIGMA SECURITIES, LLC
0.00%
Morgan Stanley - Brokerage Accounts
0.00%

About Petros Pharmaceuticals

Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
OrganisationPetros Pharmaceuticals
Headquarters1185 Avenue of the Americas, New York City, NY, 10036, US
IndustryDrug Manufacturers - Specialty & Generic
CEOFady Boctor

Key Management of Petros Pharmaceuticals

Name

Title

Mr. Joshua N. Silverman

Executive Chairman of the Board

Mr. Fady Boctor M.B.A.

President & Chief Commercial Officer

Mr. Robert Weinstein

Chief Accounting Officer, Principal Financial Officer & Principal Accounting Officer

FAQs

What is Petros Pharmaceuticals share price today?

Petros Pharmaceuticals share price today is $0.01 as on at the close of the market. Petros Pharmaceuticals share today touched a day high of $0.01 and a low of $0.01.

What is the 52 week high and 52 week low for Petros Pharmaceuticals share?

Petros Pharmaceuticals share touched a 52 week high of $0.03 on and a 52 week low of $0.00 on . Petros Pharmaceuticals stock price today i.e. is closed at $0.01,which is 72.80% down from its 52 week high and 300.00% up from its 52 week low.

What is Petros Pharmaceuticals's market capitalisation today?

Petros Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Petros Pharmaceuticals Stock (PTPI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Petros Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Petros Pharmaceuticals Stock (PTPI) from India?

Indian investors can start investing in Petros Pharmaceuticals (PTPI) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Petros Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Petros Pharmaceuticals share’s latest price of $0.01 as on October 1, 2026 at 12:35 am IST, you will get 1470.5882 shares of Petros Pharmaceuticals. Learn more about fractional shares .

What are the returns that Petros Pharmaceuticals has given to Indian investors in the last 5 years?

Petros Pharmaceuticals stock has given -100% share price returns and 29.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?